The top and efficient scientific research team is an important guarantee for pharnorcia to maintain its leading edge in technology. In China, contact lenses are three types of medical devices, providing products that not only have the function of correcting vision, but also are fast consumer goods that continue to grow. Its market is the largest market for three types of medical devices, with a market of 100 billion yuan. Enabling the industry to create a win-win situation.

The pharnorcia will also focus on the development of soft myopia suppression products and daily throwing products. Soft myopia suppression products will integrate the optical principle of slowing down vision decline and the characteristics of high oxygen permeability and extreme softness of silicon water condensation materials, create the world's top technology, benefit hundreds of millions of young people, and throw high-end medical devices with independent intellectual property rights, expand the market, replace imported and old generation products in an all-round way, pharnorcia, and enable the industry to create a win-win situation.

To ensure the effective operation of the product R & D team, it is necessary to gather more international professionals to contribute to the promotion and development of the domestic industry. In order to lead the upgrading of the domestic industry, the third generation of silicone hydrogel formula materials will be supplied to the domestic contact lens industry, creating an international monopoly pattern, breaking the status quo of industry giants controlling the supply of high-end materials at the source, pharnorcia, enabling the industry to create a win-win situation.

After the import production line is in place, the pharnorcia company will officially commercialize the sales, and will freely control the excellent water content ratio with high transparency, the appearance and industrialization of the new generation of silicone hydrogel contact lenses, and the supply of materials, so as to provide packaging for the rapid development of the enabling industry, pharnorcia, and create a win-win situation for the enabling industry.

Recommendation of relevant materials

DEGMA-CAS#:45103-58-0

DMA-CAS#:2680-03-7

GMAK-CAS#:7098-80-8

HEMA-CAS#:868-77-9